Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Clinical Medicine
|
August 10, 2019
Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis
Eloi Franco-Trepat, María Guillán-Fresco, Ana Alonso-Pérez, et al.
Frontiers in Physiology
|
June 6, 2018
Role of Toll-Like Receptor 4 on Osteoblast Metabolism and Function
Ana Alonso-Pérez, Eloi Franco-Trepat, María Guillán-Fresco, et al.
Expert Opinion on Therapeutic Targets
|
May 11, 2019
Visfatin as a therapeutic target for rheumatoid arthritis
Eloi Franco-Trepat, Ana Alonso-Pérez, María Guillán-Fresco, et al.
Journal of Clinical Medicine
|
April 25, 2020
Caffeine, a Risk Factor for Osteoarthritis and Longitudinal Bone Growth Inhibition
María Guillán-Fresco, Eloi Franco-Trepat, Ana Alonso-Pérez, et al.
International Journal of Molecular Sciences
|
February 25, 2023
Methylphenidate Promotes Premature Growth Plate Closure: In Vitro Evidence
Andrés Pazos-Pérez, María Piñeiro-Ramil, Eloi Franco-Trepat, et al.
Nutrients
|
July 14, 2023
Formononetin, a Beer Polyphenol with Catabolic Effects on Chondrocytes
María Guillán-Fresco, Eloi Franco-Trepat, Ana Alonso-Pérez, et al.
Journal of Bone and Joint Infection
|
September 27, 2019
Commercially available antibiotic-laden PMMA-covered locking nails for the treatment of fracture-related infections - A retrospective case analysis of 10 cases
Alberto Jorge-Mora, Samer Amhaz-Escanlar, Sabela Fernandez-Pose, et al.
Biomedicines
|
January 21, 2023
Improved Protocol to Study Osteoblast and Adipocyte Differentiation Balance
Ana Alonso-Pérez, María Guillán-Fresco, Eloi Franco-Trepat, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2025
Repurposed Drugs for Heterotopic Ossification Management: Revitalizing Therapeutic Strategies
Ana Alonso-Pérez, Eloi Franco-Trepat, María Guillán-Fresco, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 15, 2022
Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells
Eloi Franco-Trepat, María Guillán-Fresco, Ana Alonso-Pérez, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Clinical Medicine
|
August 10, 2019
Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis
Eloi Franco-Trepat, María Guillán-Fresco, Ana Alonso-Pérez, et al.
Frontiers in Physiology
|
June 6, 2018
Role of Toll-Like Receptor 4 on Osteoblast Metabolism and Function
Ana Alonso-Pérez, Eloi Franco-Trepat, María Guillán-Fresco, et al.
Expert Opinion on Therapeutic Targets
|
May 11, 2019
Visfatin as a therapeutic target for rheumatoid arthritis
Eloi Franco-Trepat, Ana Alonso-Pérez, María Guillán-Fresco, et al.
Journal of Clinical Medicine
|
April 25, 2020
Caffeine, a Risk Factor for Osteoarthritis and Longitudinal Bone Growth Inhibition
María Guillán-Fresco, Eloi Franco-Trepat, Ana Alonso-Pérez, et al.
International Journal of Molecular Sciences
|
February 25, 2023
Methylphenidate Promotes Premature Growth Plate Closure: In Vitro Evidence
Andrés Pazos-Pérez, María Piñeiro-Ramil, Eloi Franco-Trepat, et al.
Nutrients
|
July 14, 2023
Formononetin, a Beer Polyphenol with Catabolic Effects on Chondrocytes
María Guillán-Fresco, Eloi Franco-Trepat, Ana Alonso-Pérez, et al.
Journal of Bone and Joint Infection
|
September 27, 2019
Commercially available antibiotic-laden PMMA-covered locking nails for the treatment of fracture-related infections - A retrospective case analysis of 10 cases
Alberto Jorge-Mora, Samer Amhaz-Escanlar, Sabela Fernandez-Pose, et al.
Biomedicines
|
January 21, 2023
Improved Protocol to Study Osteoblast and Adipocyte Differentiation Balance
Ana Alonso-Pérez, María Guillán-Fresco, Eloi Franco-Trepat, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2025
Repurposed Drugs for Heterotopic Ossification Management: Revitalizing Therapeutic Strategies
Ana Alonso-Pérez, Eloi Franco-Trepat, María Guillán-Fresco, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 15, 2022
Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells
Eloi Franco-Trepat, María Guillán-Fresco, Ana Alonso-Pérez, et al.
Page
of 2